Research Papers:

64Cu-PSMA-617: A novel PSMA-targeted radio-tracer for PET imaging in gastric adenocarcinoma xenografted mice model

Xue-Di Han, Chen Liu, Fei Liu, Qing-Hua Xie, Te-Li Liu, Xiao-Yi Guo, Xiao-Xia Xu, Xing Yang, Hua Zhu _ and Zhi Yang

PDF  |  HTML  |  Supplementary Files  |  How to cite

Oncotarget. 2017; 8:74159-74169. https://doi.org/10.18632/oncotarget.18276

Metrics: PDF 2068 views  |   HTML 4429 views  |   ?  


Xue-Di Han1,*, Chen Liu1,*, Fei Liu1, Qing-Hua Xie1,2, Te-Li Liu1, Xiao-Yi Guo1, Xiao-Xia Xu1, Xing Yang3, Hua Zhu1 and Zhi Yang1

1Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Nuclear Medicine, Peking University Cancer Hospital and Institute, Beijing 100142, China

2College of Chemistry, Sichuan University, Chengdu 610064, China

3Russell H. Morgan, Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, United States

*These authors contributed equally to this work

Correspondence to:

Hua Zhu, email: [email protected]

Zhi Yang, email: [email protected]

Keywords: prostate specific membrane antigen, neo-vasculature, gastric cancer, PET, 64Cu

Received: April 14, 2017     Accepted: May 14, 2017     Published: May 26, 2017


Here, we report that it’s feasible for imaging gastric adenocarcinoma mice model with prostate-specific membrane antigen (PSMA) targeting imaging agents, which could potentially provide an alternate and readily translational tool for managing gastric adenocarcinoma. DKFZ-PSMA-617, a PSMA targeting ligand reported recently, was chosen to be radio-labeled with nuclide 64Cu. 64Cu-PSMA-617 was radio-synthesized in high radio-chemical yield and specific activity up to 19.3 GBq/μmol. It showed good stability in vitro. The specificity of 64Cu-PSMA-617 was confirmed by cell uptake experiments in PSMA (+) LNCaP cell and PSMA (-) PC-3 and gastric adenocarcinoma BGC-823 cells. Micro-PET imaging in BGC-823 and PC-3 xenografts nude mice was evaluated (n = 4). And the tumors were visualized and better tumor-to-background achieved till 24 h. Co-administration of N- [[[(1S)-1-Carboxy-3-methylbutyl]amino]-carbonyl]-L-glutamic acid (ZJ-43) can substantially block the uptake in those tumors. Dissected tumor tissues were analyzed by auto-radiography and immunohistochemistry, and these results confirmed the PSMA expression in neo-vasculature which explained the target molecular imaging of 64Cu-PSMA-617. All those results suggested 64Cu-PSMA-617 may serve as a novel radio-tracer for tumor imaging more than prostate cancer.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 18276